Switzerland Expands Pharmacy-Led Cannabis Pilot to 20 Cities

Pilot Now Covers Fifth of Swiss Population

The expanded pilot includes Basel, Bern, Geneva, Lausanne, and Zurich, reaching roughly 20% of Switzerland's population. Participants aged 18 and older register with a participating pharmacy, undergo a health screening by a pharmacist or physician, and receive a purchase card allowing up to 10 grams per month. Federal Office of Public Health (FOPH) approved the expansion based on interim safety data from the initial Basel and Zurich trials, which began in August 2023.

Each pharmacy sources cannabis from one of four licensed Swiss cultivators operating under FOPH oversight. Products are tested for potency, pesticides, and microbial contamination before distribution. THC limits remain capped at 20% for flower and 10% for concentrates—consistent with the original pilot parameters.

Safety Data Drives Federal Approval

Preliminary findings from the Basel cohort show no increase in emergency-room visits or driving incidents among registered users compared to a matched control group. According to a September 2026 FOPH briefing document, 89% of participants reported substituting pharmacy cannabis for illicit-market purchases, and 12% reduced alcohol consumption. The agency cited these outcomes as justification for the geographic expansion.

The pharmacy model appears to reduce harm by ensuring product quality and embedding health counseling at the point of sale, according to the FOPH briefing.

Researchers at the University of Basel are tracking longitudinal health outcomes, including respiratory function, mental-health markers, and substance-use patterns. Full results? Early 2029.

Pharmacists Required to Complete Training Module

Participating pharmacies must complete a 12-hour FOPH training course covering cannabinoid pharmacology, dosing guidance, contraindications, and referral protocols for problem use. Pharmacists conduct a baseline health screen before issuing a purchase card and are required to flag high-frequency purchasers for follow-up counseling. Screening includes questions about prior substance use, mental-health history, and current medications.

Pharmacies receive a per-transaction fee of 15 Swiss francs (approximately $17 USD) to offset counseling time. FOPH hasn't disclosed total program costs but confirmed that pilot funding comes from federal public-health allocations, not cannabis tax revenue.

Four Licensed Cultivators Supply Program

Swiss cultivators Pure Production AG, Medropharm, Cannical, and Emery Pharma hold the four federal licenses to supply pilot pharmacies. Each cultivator operates under Good Manufacturing Practice (GMP) standards and submits quarterly production reports to FOPH. Flower retails between 10 and 14 Swiss francs per gram, slightly below black-market pricing in Zurich and Geneva.

Cultivators can't sell pilot-program cannabis outside Switzerland or divert it to export markets. FOPH conducts unannounced facility inspections and can revoke licenses for non-compliance. No violations have been reported since the pilot launched.

Legal Status Remains Experimental

The pilot operates under a federal exemption to Switzerland's Narcotics Act, which still classifies cannabis as a controlled substance. Participants aren't permitted to grow their own cannabis, share purchases with non-registered users, or consume in public spaces. Violations can result in removal from the program and referral to local law enforcement.

Switzerland's parliament hasn't introduced legislation to legalize adult-use cannabis outside the pilot framework. FOPH has stated that any broader reform will depend on the final evaluation of the pilot program, expected in 2029. For now, the pharmacy model remains the only legal pathway for recreational access in Switzerland. Full background on the program's origins and structure is available at the CannIntel topic hub on Switzerland's cannabis pilot.

Enforcement remains fragmented. Cantonal police in Zurich and Basel have deprioritized possession arrests for small amounts, while rural cantons continue to prosecute—creating a patchwork where legality hinges on geography and registration status, a dynamic that will likely persist until federal law changes.